Cited by 844Gut microbiota and healthDermatology and Skin DiseasesProbiotics and Fermented Foods

Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study

Open access
Penders, J., Thijs, C., van den Brandt, P. A, Kummeling, I., Snijders, B., Stelma, F., Adams, H., van Ree, R. +1 more·2007·Gut

Abstract

BACKGROUND AND AIMS: Perturbations in intestinal microbiota composition due to lifestyle changes may be involved in the development of atopic diseases. We examined gut microbiota composition in early infancy and the subsequent development of atopic manifestations and sensitisation. METHODS: The faeces of 957 infants aged 1 month and participating in the KOALA Birth Cohort Study were analysed using quantitative real-time PCR. Information on atopic symptoms (eczema, wheeze) and potential confounders was acquired through repeated questionnaires. Total and specific IgE were measured in venous blood samples collected during home visits when the infant was 2 years old. During these home visits a clinical diagnosis of atopic dermatitis was made according to the UK-Working Party criteria. RESULTS: The presence of Escherichia coli was associated with a higher risk of developing eczema (OR(adj) = 1.87; 95% CI 1.15 to 3.04), this risk being increased with increasing numbers of E coli (p(for trend) = 0.016). Infants colonised with Clostridium difficile were at higher risk of developing eczema (OR(adj) = 1.40; 95% CI 1.02 to 1.91), recurrent wheeze (OR(adj) = 1.75; 95% CI 1.09 to 2.80) and allergic sensitisation (OR(adj) = 1.54; 95% CI 1.02 to 2.31). Furthermore, the presence of C difficile was also associated with a higher risk of a diagnosis of atopic dermatitis during the home visit (OR(adj) = 1.73; 95% CI 1.08 to 2.78). CONCLUSION: This study demonstrates that differences in gut microbiota composition precede the development of atopy. Since E coli was only associated with eczema and C difficile was associated with all atopic outcomes, the underlying mechanisms explaining these association may be different.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.2006.100164

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Presence of Clostridium difficile at 1 month of age is associated with increased risk for allergic sensitization (OR 1.54; 95% CI 1.09-2.31) until age 2.

    “Penders et al.447 found that the presence of Clostridium difficile at 1 month of age was associated with an increased risk for allergic sensitization (odds ratio [OR] 1.54; 95% confidence interval [CI], 1.09 to 2.31) until the age of 2 years.”

    From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [447]

    The Results report that C. difficile colonisation at 1 month was associated with atopic sensitisation within the first 2 years of life, with an adjusted OR of 1.54. The cited confidence interval is incorrect: the Results give 95% CI 1.02–2.31, not 1.09–2.31. No page number is provided in our copy. (LLM, conf=0.93)

    Experimental — accuracy not yet measured
  • The evidence supports a link between early-life microbiota composition or antibiotic use and later metabolic and immune function, specifically overweight/obesity and asthma/allergy.

    “The evidence supports a link between early-life microbiota composition, or antibiotic use, and later metabolic and immune function (specifically overweight/obesity and asthma/allergy; Abrahamsson et al., 2014;Azad et al., 2014;Penders et al., 2007;Sjogren et al., 2009;Stanislawski et al., 2018a;Sugino et al., 2019).”

    From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Penders et al., 2007

    The Abstract (page unavailable in our copy) reports that gut microbiota composition at one month was associated with eczema, recurrent wheeze and allergic sensitisation during the first two years. The discussion (page unavailable) says antibiotic therapy can perturb infant gut microbiota, but this study does not establish an antibiotic-use link to those later outcomes. It does not report overweight or obesity outcomes, and describes asthma as a possible outcome requiring longer follow-up. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005;54:317-20.

Cited by

Sorted by citations

Authors
Penders, J., Thijs, C., van den Brandt, P. A., Kummeling, I., Snijders, B., Stelma, F., Adams, H., van Ree, R., & Stobberingh, E. E.
Affiliations
  • Maastricht University (NL)
  • Maastricht University Medical Centre (NL)
Corresponding author
Penders, J.
Venue
Gut
Publisher
BMJ
Published
2007-05-01
Volume
56
Issue
5
Pages
661-667
ISSN
0017-5749 (ISSN-L)
OpenAlex
W2167142729
Cited by
844
References
62
Citations by year
2026: 19 · 2025: 38 · 2024: 28 · 2023: 43 · 2022: 42 · 2021: 42 · 2020: 46 · 2019: 55 · 2018: 50 · 2017: 47 · 2016: 64 · 2015: 42 · 2014: 56 · 2013: 48 · 2012: 48
FWCI
12.11
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
gut microbiota, atopic dermatitis, wheezing, atopic sensitization, Escherichia coli, Clostridium difficile, fecal microbiota, early infancy
MeSH terms
Bacteria, Dermatitis, Atopic, DNA, Bacterial, Escherichia coli, Feces, Female, Follow-Up Studies, Humans, Hypersensitivity, Immediate, Immunoglobulin E, Infant, Male, Prospective Studies, Respiratory Hypersensitivity, Respiratory Sounds, Polymerase Chain Reaction, Clostridioides difficile

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review